Clinical Trials Directory

Trials / Unknown

UnknownNCT05385822

Pelvic Floor Muscle Training in the Treatment of Erectile Dysfunction

Pelvic Floor Muscle Training in the Treatment of Erectile Dysfunction: A Randomized, Controlled Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
Herlev and Gentofte Hospital · Academic / Other
Sex
Male
Age
30 Years – 70 Years
Healthy volunteers
Accepted

Summary

Erectile dysfunction affects about 40% of all men above the age of 40 and the prevalence increases with increasing age. It is not possible to cure the condition as current forms of treatment are aimed solely at improving symptoms. Treatment options today include medications, injection therapy, and vacuum pumps, among others. However, pelvic floor muscle training is a natural, inexpensive, and non-invasive form of treatment that is used to a limited extent. Theoretically, a strengthening of the pelvic floor muscles can help increase the intracavernous pressure and thereby the hardness of the erection. Furthermore, tense pelvic floor muscles can help compress pelvic veins and reduce blood flow away from the penis which prolongs the erection. Finally, it is possible that pelvic floor muscle training can contribute to an increased blood supply to the pelvic floor and the penis which will have positive effects in relation to both the integrity of the penile tissue and the physiological erection mechanism itself. This study aims to investigate the effect of pelvic floor muscle training in men with erectile dysfunction. The study hypothesis is that pelvic floor training can provide a clinically significant improvement in the erection function at individual patient level

Conditions

Interventions

TypeNameDescription
BEHAVIORALPelvic Floor Muscle Training* Isolated, quite light tension in the pelvic floor 10 times, where the tension is released immediately * Constant tension for 30 seconds twice, with a 30-second pause * Total relaxation for 1 minute They must perform these exercises once a day during the trial period of 3 months

Timeline

Start date
2022-05-01
Primary completion
2024-03-01
Completion
2025-03-01
First posted
2022-05-23
Last updated
2022-05-23

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT05385822. Inclusion in this directory is not an endorsement.